Increases the efficacy of anthracycline therapy in cancer treatments. Reduces the cost of treating cancer patients due to more effective drugs used. Results in healthier cancer patients after treatment due to the reduced amount of metabolites causing cardiotoxicity.
[更多]
University researchers have developed a nanotechnology for innovative new drug delivery capability, i.e., new nanotechnology-based, magnetically or ultrasonically switchable drug delivery vehicles with easy, remotely on-off switchable release capability. Three types of embodiments of the actuate-abl.....
[更多]
These features should prove extremely relevant for clinical applications, from cancer to ophthalmology, where increased efficacy and reduce drug toxicity can enhance the therapeutic profile and/or extend patient life for promising and useful drugs.
[更多]
Established IgA producing cell lines can be transfected with the SC component to produce sIgA with identical specificity. Can create new sIgA monoclonal antibodies produced in large quantities from a single cell line using standard antibody production techniques. sIgA has increased stability compa.....
[更多]
In broad terms, the PCSD1 model is more representative and predictive of the bone metastatic prostate cancer tumors found in patients. Specifically: Current prostate cancer cell line (SCID mouse) xenograft models, include: - PC3, which produces purely osteolytic lesions in intra-tibial xeno.....
[更多]
| |< <- | [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] | -> >| |
